Medical Developments International Limited
Symbool: MVP.AX
ASX
0.59
AUDMarktprijs vandaag
-1.9991
Koers/Winst Verhouding
-0.0070
Koers/Winst Groei Verhouding
50.92M
MRK Kapitalisatie
- 0.00%
DIV Rendement
Medical Developments International Limited (MVP-AX) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 24.7 | 20.4 | 36.3 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 8.9 | 6.2 | 5 | |||||||||||||||||||||
balance-sheet.row.inventory | 0 | 8.4 | 7.1 | 5.7 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 0.8 | 0.6 | 0.4 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 42.8 | 34.4 | 47.4 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 12.1 | 11.6 | 11.7 | |||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 3.8 | 3.8 | 4.4 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 8.5 | 8 | 8.2 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 12.3 | 11.8 | 12.6 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | -3.8 | -3.8 | -4.4 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 16.3 | 14.8 | 2.2 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 29.9 | 32.7 | 30.6 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 66.7 | 67 | 52.8 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 109.5 | 101.4 | 100.2 | |||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 13.3 | 9.4 | 3.3 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 0.4 | 0.3 | 0.3 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 2.2 | 2.5 | 2.7 | |||||||||||||||||||||
Deferred Revenue Non Current | 0 | 1.9 | 21.6 | 21.9 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 1.6 | 0.7 | 3.3 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 12.6 | 33.6 | 24.9 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 2.2 | 2.5 | 2.7 | |||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 28.2 | 44.1 | 31.9 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 105.7 | 77 | 76.9 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -30.2 | -24.5 | -12.1 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 5.7 | 4.9 | 3.5 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 81.3 | 57.3 | 68.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 109.5 | 101.4 | 100.2 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 81.3 | 57.3 | 68.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||
Total Investments | 0 | -3.8 | -3.8 | -4.4 | |||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 2.6 | 2.8 | 3 | |||||||||||||||||||||
balance-sheet.row.net-debt | 0 | -22.1 | -17.6 | -33.2 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -5.6 | -12.4 | -12.6 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 3.1 | 2.9 | 3.7 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -7.4 | -8.4 | -0.1 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 1.3 | 1 | 1.2 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -2.5 | -3.6 | -9.9 | ||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -2.9 | -2.5 | 1.4 | ||||||||||||||||||||
cash-flows.row.inventory | 0 | -1.8 | -1.4 | 0.2 | ||||||||||||||||||||
cash-flows.row.account-payables | 0 | 4.8 | 2.3 | 1 | ||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -2.6 | -2.1 | -12.5 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -5.4 | 9.8 | 8.9 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -7.7 | -5.2 | -6.6 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -7.7 | -5.2 | -6.6 | ||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -0.3 | -0.2 | -0.1 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 28.3 | 0.4 | 36.3 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -1.7 | 0 | -0.7 | ||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -26.4 | -0.1 | -35.5 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 28.1 | 0.1 | 36.1 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 28.1 | 0.1 | 36.1 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.4 | -0.1 | 0 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 4.3 | -15.9 | 20.7 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 24.7 | 20.4 | 36.3 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 20.4 | 36.3 | 15.5 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -16.5 | -10.7 | -8.8 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -7.7 | -5.2 | -6.6 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -24.2 | -15.9 | -15.4 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 32.3 | 21.9 | 25.3 | |||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 34.9 | 25 | 8.6 | |||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | -2.5 | -3.1 | 16.7 | |||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 19.1 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 17.8 | 12.6 | 21.9 | |||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 52.6 | 37.6 | 30.5 | |||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 0.7 | 0.5 | 0.1 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 12.8 | -0.2 | -9.7 | |||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 19.1 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 12.8 | -0.2 | -9.7 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 3.1 | 2.9 | 3.7 | |||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.operating-income | 0 | -20.3 | -15.7 | -5.2 | |||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -7.5 | -15.9 | -15 | |||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -1.9 | -3.5 | -2.4 | |||||||||||||||||||||
income-statement-row.row.net-income | 0 | -5.6 | -12.4 | -12.6 |
Vaak gestelde vragen
Wat is Medical Developments International Limited (MVP.AX) totale activa?
Medical Developments International Limited (MVP.AX) totale activa is 109486000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is -0.215.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is -0.574.
Wat is de totale omzet van de onderneming?
De totale opbrengst is -0.750.
Wat is Medical Developments International Limited (MVP.AX) nettowinst (netto-inkomen)?
De nettowinst is -5609000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 2560000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 17757000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.